162 related articles for article (PubMed ID: 12866973)
1. [Research advances on inhibitor of apoptosis, survivin].
Yang J; Liu FX; Yan XC
Ai Zheng; 2003 Jul; 22(7):771-4. PubMed ID: 12866973
[TBL] [Abstract][Full Text] [Related]
2. The role of survivin as a new target of diagnosis and treatment in human cancer.
Yamamoto T; Tanigawa N
Med Electron Microsc; 2001 Dec; 34(4):207-12. PubMed ID: 11956993
[TBL] [Abstract][Full Text] [Related]
3. Survivin regulates the p53 tumor suppressor gene family.
Wang Z; Fukuda S; Pelus LM
Oncogene; 2004 Oct; 23(49):8146-53. PubMed ID: 15361831
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth.
Chen J; Wu W; Tahir SK; Kroeger PE; Rosenberg SH; Cowsert LM; Bennett F; Krajewski S; Krajewska M; Welsh K; Reed JC; Ng SC
Neoplasia; 2000; 2(3):235-41. PubMed ID: 10935509
[TBL] [Abstract][Full Text] [Related]
5. Survivin and caspase-3 expression in breast cancer: correlation with prognostic parameters, proliferation, angiogenesis, and outcome.
Nassar A; Lawson D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):113-20. PubMed ID: 18227733
[TBL] [Abstract][Full Text] [Related]
6. Survivin, versatile modulation of cell division and apoptosis in cancer.
Altieri DC
Oncogene; 2003 Nov; 22(53):8581-9. PubMed ID: 14634620
[TBL] [Abstract][Full Text] [Related]
7. Survivin and apoptosis control.
Altieri DC
Adv Cancer Res; 2003; 88():31-52. PubMed ID: 12665052
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
9. [Development of a novel gene therapy using survivin antisense expressing adenoviral vectors].
Yamamoto T; Manome Y; Miyamoto A; Tanigawa N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1805-8. PubMed ID: 14619525
[TBL] [Abstract][Full Text] [Related]
10. Survivin as a target for new anticancer interventions.
Zaffaroni N; Pennati M; Daidone MG
J Cell Mol Med; 2005; 9(2):360-72. PubMed ID: 15963255
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of apoptosis protein inhibitor survivin and XIAP, in patients with myelodysplastic syndromes and in the cell line MUTZ-1].
Cai Z; Bao HY; Ludwig WD; Wuchter C
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):26-30. PubMed ID: 14990073
[TBL] [Abstract][Full Text] [Related]
12. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Mita AC; Mita MM; Nawrocki ST; Giles FJ
Clin Cancer Res; 2008 Aug; 14(16):5000-5. PubMed ID: 18698017
[TBL] [Abstract][Full Text] [Related]
13. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
14. Survivin: a protein with dual roles in mitosis and apoptosis.
Wheatley SP; McNeish IA
Int Rev Cytol; 2005; 247():35-88. PubMed ID: 16344111
[TBL] [Abstract][Full Text] [Related]
15. Survivin and leukemia.
Cong XL; Han ZC
Int J Hematol; 2004 Oct; 80(3):232-8. PubMed ID: 15540897
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.
Tu SP; Cui JT; Liston P; Huajiang X; Xu R; Lin MC; Zhu YB; Zou B; Ng SS; Jiang SH; Xia HH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC
Gastroenterology; 2005 Feb; 128(2):361-75. PubMed ID: 15685548
[TBL] [Abstract][Full Text] [Related]
17. Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis.
Beltrami E; Plescia J; Wilkinson JC; Duckett CS; Altieri DC
J Biol Chem; 2004 Jan; 279(3):2077-84. PubMed ID: 14581472
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.
Malcles MH; Wang HW; Koumi A; Tsai YH; Yu M; Godfrey A; Boshoff C
Br J Cancer; 2007 Jun; 96(11):1659-66. PubMed ID: 17505517
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
20. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
